|1|Prevalence of IVS10nt-18G/A in Calabrian patients with moderate/mild hemophilia A and relation with Factor VIII inhibitor antibodies. (26182242)
PrejanA^ S.... Iannaccaro P.
|2|Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogeneic but not autologous factor VIII activity. (26278069)
Yada K.... Shima M.
|3|Overrepresentation of missense mutations in mild hemophilia A patients from Belgium: founder effect or independent occurrence? (25824987)
Lannoy N.... Hermans C.
|4|Life-threatening bleeding in a patient with mild hemophilia A and heterozygosity for von Willebrand disease Type 2N. (25212677)
Allan J.N.... Desancho M.T.
|5|Desmopressin responsiveness at a capped dose of 15a88I1g in type 1 von Willebrand disease and mild hemophilia A. (24911459)
Siew D.A.... Minuk L.
|6|Molecular and clinical predictors of inhibitor risk and its prevention and treatment in mild hemophilia A. (25139352)
Castaman G.... Fijnvandraat K.
|7|Co-inheritance of mild hemophilia A and heterozygosity for type 2N von Willebrand disease: a diagnostic and therapeutic challenge. (24706524)
Lindsay H.... Srivaths L.
|8|Clinical efficacy and determinants of response to treatment with desmopressin in mild hemophilia a. (24030345)
Di Perna C.... Tagliaferri A.
|9|Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A. (23812942)
Bowyer A.E.... Makris M.
|10|Diagnostic testing for mild hemophilia a in patients with discrepant one-stage, two-stage, and chromogenic factor VIII:C assays. (23460037)
Duncan E.M.... McRae S.J.
|11|Prevalence, biological phenotype and genotype in moderate/mild hemophilia A with discrepancy between one-stage and chromogenic factor VIII activity. (21166991)
TrossaArt M.... Bezieau S.
|12|Deep intronic variations may cause mild hemophilia A. (21689372)
Castaman G.... Rodeghiero F.
Franchini M.... Lippi G.
|14|The use of desmopressin in mild hemophilia A. (20829683)
Franchini M.... Lippi G.
|15|Characterization of a novel mutation in the F8 promoter region associated with mild hemophilia A and resistance to DDAVP therapy. (19422439)
Riccardi F.... Tagliaferri A.
|16|Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A. (19719828)
Castaman G.... Rodeghiero F.
|17|Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions. (19506355)
|18|Maxillary hemophilic pseudotumor in a patient with mild hemophilia A. (18799938)
Lima G.S.... Dias E.P.
|19|Founder haplotype associated with the factor VIII Asp1241Glu polymorphism in a cohort of mild hemophilia A patients. (18419741)
CasaA+a P.... Aznar J.A.
|20|Health-related quality of life in a cohort of adult patients with mild hemophilia A. (18284605)
Walsh M.... Scully M.F.
|21|Screening of mutations of hemophilia A in 40 Italian patients: a novel G-to-A mutation in intron 10 of the F8 gene as a putative cause of mild hemophilia A in southern Italy. (18388498)
Santacroce R.... Margaglione M.
|22|Mild hemophilia A with factor VIII assay discrepancy: using thrombin generation assay to assess the bleeding phenotype. (18047548)
TrossaArt M.... Lecompte T.
|23|Superficial fibromatosis mimicking subcutaneous hematoma: an unusual and difficult diagnosis in a patient with mild hemophilia A. (17261494)
Sakurai Y.... Yoshioka A.
|24|Exon skipping partially restores factor VIII coagulant activity in patients with mild hemophilia A with exon 13 duplication. (15996947)
Acquila M.... Bicocchi M.P.
|25|Deletion of alanine 2201 in the FVIII C2 domain results in mild hemophilia A by impairing FVIII binding to VWF and phospholipids and destroys a major FVIII antigenic determinant involved in inhibitor development. (12969981)
D'Oiron R.... Jacquemin M.
|26|Desmopressin in mild hemophilia A: indications, limitations, efficacy, and safety. (12640572)
|27|Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease. (12032528)
Gill J.C.... Schwartz B.
|28|A founder factor VIII mutation, valine 2016 to alanine, in a population with an extraordinarily high prevalence of mild hemophilia A. (11848452)
Xie Y.G.... Lillicrap D.
|29|Skewed X-chromosome inactivation in monochorionic diamniotic twin sisters results in severe and mild hemophilia A. (12351418)
Valleix S.... Negrier C.
|30|Successful treatment of high titer inhibitors in mild hemophilia A with avoidance of factor VIII and immunosuppressive therapy. (11754400)
Robbins D.... Penner J.A.
|31|Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivo. (9864159)
Pipe S.W.... Kaufman R.J.
|32|Antifactor VIII antibody inhibiting allogeneic but not autologous factor VIII in patients with mild hemophilia A. (10090936)
Peerlinck K.... Vermylen J.
|33|Factor VIII Ise (R2159C) in a patient with mild hemophilia A, an abnormal factor VIII with retention of function but modification of C2 epitopes. (9184393)
Suzuki H.... Yoshioka A.
|34|Missense mutations causing mild hemophilia A in Iceland detected by denaturing gradient gel electrophoresis. (1301960)
Jonsdottir S.... Gitschier J.
|35|Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I. (2107887)
Lethagen S.... Nilsson I.M.
|36|Mild hemophilia A resulting from Arg-to-Leu substitution in exon 26 of the factor VIII gene. (2495245)
Inaba H.... Antonarakis S.E.